VAGO, LUCA ALDO EDOARDO
 Distribuzione geografica
Continente #
EU - Europa 1.133
NA - Nord America 817
AS - Asia 549
OC - Oceania 10
SA - Sud America 8
AF - Africa 3
Totale 2.520
Nazione #
US - Stati Uniti d'America 807
SE - Svezia 618
SG - Singapore 254
IT - Italia 213
RU - Federazione Russa 195
CN - Cina 148
HK - Hong Kong 69
JP - Giappone 38
FI - Finlandia 36
DE - Germania 18
IE - Irlanda 16
IN - India 12
IR - Iran 11
AU - Australia 10
CA - Canada 10
GB - Regno Unito 9
SA - Arabia Saudita 9
FR - Francia 7
AT - Austria 5
HU - Ungheria 5
BR - Brasile 4
CL - Cile 4
CH - Svizzera 3
IL - Israele 3
PK - Pakistan 3
DZ - Algeria 2
NL - Olanda 2
CZ - Repubblica Ceca 1
EG - Egitto 1
ES - Italia 1
IQ - Iraq 1
LT - Lituania 1
MK - Macedonia 1
RS - Serbia 1
TH - Thailandia 1
UA - Ucraina 1
Totale 2.520
Città #
Lawrence 225
Princeton 225
Singapore 168
Shanghai 96
Milan 87
Moscow 70
Ashburn 60
New York 48
Helsinki 36
Boardman 28
Dublin 16
Chaoyang 10
Tokyo 9
Washington 8
Gorgonzola 7
Rome 7
Seattle 7
Beijing 6
Bologna 6
Los Angeles 6
Borås 5
Budapest 5
Falls Church 5
Hanover 5
Jeddah 5
New Haven 5
Overland Park 5
Perth 5
Aci Sant'Antonio 4
Andover 4
Baltimore 4
Elsternwick 4
Montreal 4
Naples 4
Pune 4
San Jose 4
Santiago 4
Ferrara 3
Genoa 3
Ibaraki 3
Iowa City 3
Kfar Saba 3
Oberndorf bei Salzburg 3
Phoenix 3
Pisa 3
Segrate 3
Turin 3
Alagappapuram 2
Bergamo 2
Bordeaux 2
Boston 2
Castelli Calepio 2
Castelseprio 2
Central 2
Cinisello Balsamo 2
Crotone 2
Dallas 2
Des Moines 2
Edgware 2
Ekimaedori 2
Figline Valdarno 2
Florence 2
Guangzhou 2
Hong Kong 2
Kolkata 2
Livorno 2
L’Aquila 2
Maple 2
Mestre 2
Modena 2
Muzaffargarh 2
Nanjing 2
Padova 2
Palermo 2
Paris 2
Redwood City 2
Sheffield 2
Siena 2
St Louis 2
Surat 2
São Paulo 2
Toronto 2
Vanzago 2
Vienna 2
Westmont 2
Xian 2
Zurich 2
Aioicho 1
Albuquerque 1
Bangalore 1
Bangkok 1
Besana In Brianza 1
Boydton 1
Brierley Hill 1
Cambridge 1
Chicago 1
Clifton 1
Cormano 1
Duncan 1
Essen 1
Totale 1.324
Nome #
MODELING ADOPTIVE IMMUNOTHERAPY IN MOUSE-HUMANS CHIMERAS TO IDENTIFY NOVEL MECHANISMS OF LEUKEMIA IMMUNOEDITING 71
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study 63
Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation 38
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors 34
QUANTITATIVE PCR-BASED CHIMERISM MONITORING IN BONE MARROW OR PERIPHERAL BLOOD TO PREDICT LEUKAEMIA RELAPSE IN HIGH-RISK PATIENTS: FINAL RESULTS OF THE KIM-PB PROSPECTIVE STUDY 33
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function 32
Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovir 31
Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors 31
Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience 31
Immunoediting of the genomic and transcriptional profile of acute myeloid leukaemia in response to allogeneic haematopoietic stem cell transplantation 27
Results from the HLA COVID-Italia study: An unexpected correlation between HLA-DP antigen load and COVID-19 severity 26
Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory 26
Quantitative polymerase chain reaction-based chimerism in bone marrow or peripheral blood to predict acute myeloid leukemia relapse in high-risk patients: results from the KIM-PB prospective study 26
Anidulafungin primary prophylaxis in 28 high-risk patients undergoing allogeneic haematopoietic stem cell transplantation: a single-centre experience 25
PROFILING THE MUTATIONAL LANDSCAPE OF ACUTE MYELOID LEUKEMIA AT RELAPSE AFTER CHEMOTHERAPY AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION 24
Loss of mismatched HLA in leukemia after stem-cell transplantation 23
Genomic Loss of Mismatched Human Leukocyte Antigen and Leukemia Immune Escape From Haploidentical Graft-Versus-Leukemia 23
Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell Transplant 23
Integrated Multiomic Profiling Identifies the Epigenetic Regulator PRC2 as a Therapeutic Target to Counteract Leukemia Immune Escape and Relapse 22
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. 21
T Cell Suicide Gene Therapy Prompts Thymic Renewal in Adults After Haploidentical Hematopoietic Stem Cell Transplantation in the Absence of Post-Transplant Immunesuppression 21
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation 21
A Mechanistic Role For Mir-126, a Hematopoietic Stem Cell Microrna, In Acute Leukemias 20
Graft-versus-lymphoma effect inside the central nervous system in a patient with extranodal natural killer/T-cell lymphoma, nasal type 20
CRISPR/CAS9-BASED GENOME EDITING TO MODEL THE ANTI-LEUKEMIA IMMUNE RESPONSE AND IDENTIFY ITS MOLECULAR PLAYERS 19
Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia 19
Targeting WT1 reactivation in patients in complete remission after allogeneic haematopoietic stem cell transplantation for AML and MDS: results in 111 patients 19
Atypical acute myeloid leukemia-specific transcripts generate shared and immunogenic MHC class-I-associated epitopes 19
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study 18
A new tool for rapid and reliable diagnosis of HLA loss relapses after HSCT 18
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients 18
Improving the Diagnostic Algorithm for Sepsis: Adjuvant Role of SeptiFast in 491 Consecutive Hematological Patients 18
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia 17
Allogeneic haematopoietic stem cell transplantation in refractory neuromyelitis optica spectrum disorders 17
Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWP 17
NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease 17
Longitudinal qPCR monitoring of nucleophosmin 1 mutations after allogeneic hematopoietic stem cell transplantation to predict AML relapse 17
Longitudinal microbiome profile associates with the risk of major transplant-related complications in allogeneic HSCT recipients 17
Clinical and molecular features associated with acute myeloid leukemia engraftment in immunodeficient mouse models 17
Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody 17
Improving the safety of cell therapy with the TK-suicide gene. 16
Genomic typing for patient-specific human leukocyte antigen-alleles is an efficient tool for relapse detection of high-risk hematopoietic malignancies after stem cell transplantation from alternative donors 16
Facing the Rising Tide of Multidrug Resistant Gram-Negative Pathogens in Allogeneic HSCT with Nanosphere's Verigene((R)) System 16
Allelic HLA Matching and Pair Origin Are Favorable Prognostic Factors for Unrelated Hematopoietic Stem Cell Transplantation in Neoplastic Hematologic Diseases: An Italian Analysis by the Gruppo Italiano Trapianto di Cellule Staminali e Terapie Cellulari, Italian Bone Marrow Donor Registry, and Associazione Italiana di Immunogenetica e Biologia dei Trapianti 16
Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on Cytomegalovirus reactivation risk after allogeneichematopoietic stem cell transplantation 15
Erratum: Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory (Science Translational Medicine (2015) 7:319 (319er9)) 15
Human Herpesvirus 6 Infection Following Haploidentical Transplantation: Immune Recovery and Outcome 15
Comparative evaluation of biological HLA-DPB1 mismatch models for survival and graft versus host disease prediction after unrelated donor hematopoietic cell transplantation 15
Acute Myeloid Leukemia Relapses after Allogenenic HSCT Display a Distinctive Immune-Related Signature, with Frequent and Functionally Relevant Alterations in HLA Class II Antigen Presentation and T Cell Costimulation 15
Allogeneic Hematopoietic Stem Cell Transplantation For Severe Neuromyelitis Optica 15
TREOSULFAN-BASED CONDITIONING AND UNMANIPULATED PERIPHERAL BLOOD HAPLOIDENTICAL TRANSPLANTATION (HAPLOSCT) FOR PRIMARY REFRACTORY AND RELAPSED AML: RESULTS IN 63 PATIENTS 15
Mechanisms of Leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation 15
Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation 14
Alterations in the genomic and transcriptional profile of leukemia upon the immune pressure of allogenic hematopoietic stem cell transplantation: tracking immunoediting by high-throughput techniques 14
Early and Effective Immune-Recovery by Gene-Engineered Lymphocytes after Haploidentical Transplantation for Leukemia Abate Late Transplant Mortality 14
Droplet digital polymerase chain reaction for DNMT3A and IDH1/2 mutations to improve early detection of acute myeloid leukemia relapse after allogeneic hematopoietic stem cell transplantation 14
NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: Dynamics and clinical implications 14
Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT 14
Antifungal Prophylaxis with Posaconazole in Allogeneic Hematopoietic Stem Cell Transplantation Using Sirolimus for Prevention of Graft-Versus-Host Disease 14
Frequency and targeted detection of HILA-DPB1 alleles encoding non-permissive transplantation antigens 14
Rapid and effective immune reconstitution with HSV-TK engineered donor lymphocyte add-backs after Haplo-HSCT 13
Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation 13
Genomic loss of mismatched HLA in leukemia is a major mechanism of in vivo escape from T cell immunosurveillance following haploidentical hematopoietic stem cell transplantation 13
Haploidentical HSCT: a 15-year experience at San Raffaele. 13
The effect of donor-recipient KIR ligand incompatibility after haploidentical hematopoietic stem cell transplantation is overruled by biological characteristics of early reconstituting NK cells with impaired graft versus leukemia activity 13
Integrating a prospective pilot trial and patient-derived xenografts to trace metabolic changes associated with acute myeloid leukemia 13
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells 13
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients 13
Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T EMRA lymphocytes 13
Significantly higher frequencies of alloreactive CD4(+) T cells responding to nonpermissive than to permissive HLA-DPB1 T-cell epitope disparities 13
Mutation at Positively Selected Positions in the Binding Site for HLA-C Shows That KIR2DL1 Is a More Refined but Less Adaptable NK Cell Receptor Than KIR2DL3 13
Early post-allogeneic transplantation WT1 transcript positivity predicts AML relapse 13
LONG-TERM DISEASE CONTROL OF REFRACTORY NEUROMYELITIS OPTICA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION 13
ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA AND NORMAL KARYOTYPE HAVE A FAVOURABLE OUTCOME AFTER INTENSIVE THERAPEUTIC PROGRAMS 13
Anidulafungin primary antifungal prophylaxis in 36 high-risk haematological patients undergoing haematopoietic stem cell transplantation 12
HAPLO-SCT WITH TK plus LYMPHOCYTES PRODUCE LEUKEMIA FREE SURVIVAL COMPARABLE TO UNRELATED BONE MARROW AND CORD BLOOD TRANSPLANTATION IN HIGH RISK ACUTE LEUKEMIA: 'TK007' PHASE II STUDY FINAL ANALYSIS 12
Loss of Mismatched HLA as a Mechanism of Leukemia Immune Escape in Family Haploidentical and Unrelated HSCT: Analysis of 103 Transplants From Alternative Donors 12
VORICONAZOLE PROPHYLAXIS OF INVASIVE FUNGAL INFECTION IN HAPLOIDENTICAL ALLOGENIC STEM CELL TRANSPLANTATION 12
RETROSPECTIVE ANALYSIS OF HIGH-RISK MYELODYSPLASTIC SYNDROME AND SECONDARY ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH ALLOGENEIC TRANSPLANTATION AT SAN RAFFAELE SCIENTIFIC INSTITUTE: A SINGLE CENTER EXPERIENCE 12
AN INNOVATIVE HUMANIZED MOUSE MODEL TO INVESTIGATE THE INTERPLAY BETWEEN IMMUNE SYSTEM AND ACUTE MYELOID LEUKEMIA IN ALLOGENEIC HSCT 12
T-Cell Replete Haploidentical PBSC Transplantation Using Intensified Myeloablative Conditioning, Post-Transplant Cyclophosphamide and Sirolimus 12
An Accelerated CD8+, but Not CD4+, T-Cell Reconstitution Associates with a More Favorable Outcome Following HLA-Haploidentical HSCT: Results from a Retrospective Study of the Cell Therapy and Immunobiology Working Party of the EBMT 12
Loss of Mismatched HLA At Leukemia Relapse After Hematopoietic Stem Cell Transplantation Is Significantly Associated with Clinical and Immunogenetic Hallmarks of Donor-Versus-Host Alloreactivity 12
Experts' considerations on HLA-haploidentical stem cell transplantation 11
Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells 11
TK007 phase II study final analysis. Genetically modified donor lymphocytes abate transplant related mortality and increase leukaemia-free survival providing early immune reconstitution after haploidentical haematopoietic stem cell transplantation 11
Timing and rate of success in transplant of MUD searches through BMDW: the real case of CIC-813 in 2006–2009 11
The impact of amino acid variability on alloreactivity defines a functional distance predictive of permissive HLA-DPB1 mismatches in hematopoietic stem cell transplantation 11
Temporal, quantitative and functional characteristics of Single-KIR positive alloreactive NK cell recovery account for impaired graft versus leukemia activity after haploidentical HSCT 11
Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting 11
Frequency and targeted detection of HLA-DPB1 T cell epitope disparities relevant in unrelated hematopoietic stem cell transplantation 11
Quantitative PCR for ins/del polymorphisms is a reliable and sensitive tool for host chimerism analysis after allogeneic hematopoietic stem cell transplantation 11
Clonal evolution and immune evasion in posttransplantation relapses 11
Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T-EMRA lymphocytes 11
Epidemiology and biology of relapse after stem cell transplantation 11
Kinetics of acute and chronic GvHD control by ganciclovir in-vivo HSV-TK suicide gene activation: long-term GvHD-free survival in 57 patients after haploidentical TK-cells 11
ALLOGENEIC STEM CELL TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES: 4GY TBI TO INTENSIFY TREOSULFAN AND FLUDARABINE-BASED CONDITIONING 11
T CELL ORIGIN OF CYTOKINE INDUCED KILLER CELLS 11
Human herpesvirus 6-specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients 10
SUICIDE GENE TRANSFER INTO DONOR LYMPHOCYTES ALLOWS EARLY AND EFFECTIVE IMMUNE-RECONSTITUTION AFTER FAMILY HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR LEUKEMIAS: RESULTS OF THE TK007 STUDY 10
Totale 1.767
Categoria #
all - tutte 47.126
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.126


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 2 0 0 0 0 0 0 0 0
2020/2021142 0 0 0 6 2 1 126 2 5 0 0 0
2021/2022144 0 0 0 34 12 8 6 21 22 18 10 13
2022/20231.263 493 293 82 10 43 136 38 79 49 14 17 9
2023/2024670 32 29 61 66 44 87 106 56 12 23 30 124
2024/2025480 429 51 0 0 0 0 0 0 0 0 0 0
Totale 2.761